nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—PRKD1—schizophrenia	0.265	0.372	CbGaD
Crizotinib—FES—schizophrenia	0.265	0.372	CbGaD
Crizotinib—ANKK1—schizophrenia	0.171	0.239	CbGaD
Crizotinib—ABCB1—schizophrenia	0.0126	0.0176	CbGaD
Crizotinib—CSF1R—forebrain—schizophrenia	0.000218	0.00182	CbGeAlD
Crizotinib—JAK2—gonad—schizophrenia	0.000218	0.00182	CbGeAlD
Crizotinib—AURKA—nervous system—schizophrenia	0.000218	0.00182	CbGeAlD
Crizotinib—MAP3K12—endocrine gland—schizophrenia	0.000217	0.00181	CbGeAlD
Crizotinib—ACVR1—endocrine gland—schizophrenia	0.000217	0.00181	CbGeAlD
Crizotinib—FLT3—endocrine gland—schizophrenia	0.000217	0.00181	CbGeAlD
Crizotinib—TNK2—cerebellum—schizophrenia	0.000216	0.0018	CbGeAlD
Crizotinib—IGF1R—cerebellum—schizophrenia	0.000216	0.0018	CbGeAlD
Crizotinib—CDK7—brain—schizophrenia	0.000216	0.0018	CbGeAlD
Crizotinib—TESK1—nervous system—schizophrenia	0.000216	0.0018	CbGeAlD
Crizotinib—TIE1—central nervous system—schizophrenia	0.000215	0.0018	CbGeAlD
Crizotinib—MAP3K2—blood—schizophrenia	0.000215	0.00179	CbGeAlD
Crizotinib—TAOK2—brain—schizophrenia	0.000215	0.00179	CbGeAlD
Crizotinib—MAP4K2—cerebellum—schizophrenia	0.000213	0.00178	CbGeAlD
Crizotinib—STK35—endocrine gland—schizophrenia	0.000213	0.00178	CbGeAlD
Crizotinib—STK3—cerebellum—schizophrenia	0.000211	0.00176	CbGeAlD
Crizotinib—TIE1—cerebellum—schizophrenia	0.000211	0.00176	CbGeAlD
Crizotinib—MERTK—nervous system—schizophrenia	0.00021	0.00175	CbGeAlD
Crizotinib—TBK1—blood—schizophrenia	0.00021	0.00175	CbGeAlD
Crizotinib—PTK2—blood—schizophrenia	0.00021	0.00175	CbGeAlD
Crizotinib—MAP4K5—gonad—schizophrenia	0.00021	0.00175	CbGeAlD
Crizotinib—MAP3K3—gonad—schizophrenia	0.00021	0.00175	CbGeAlD
Crizotinib—AURKA—central nervous system—schizophrenia	0.00021	0.00175	CbGeAlD
Crizotinib—TYK2—blood—schizophrenia	0.000209	0.00174	CbGeAlD
Crizotinib—TESK1—central nervous system—schizophrenia	0.000208	0.00174	CbGeAlD
Crizotinib—TBK1—midbrain—schizophrenia	0.000208	0.00173	CbGeAlD
Crizotinib—PTK2—midbrain—schizophrenia	0.000208	0.00173	CbGeAlD
Crizotinib—EPHA3—brain—schizophrenia	0.000207	0.00172	CbGeAlD
Crizotinib—ACVR1B—brain—schizophrenia	0.000207	0.00172	CbGeAlD
Crizotinib—TYK2—midbrain—schizophrenia	0.000206	0.00172	CbGeAlD
Crizotinib—IRAK1—blood—schizophrenia	0.000206	0.00172	CbGeAlD
Crizotinib—LIMK2—nervous system—schizophrenia	0.000206	0.00172	CbGeAlD
Crizotinib—BMP2K—endocrine gland—schizophrenia	0.000205	0.00171	CbGeAlD
Crizotinib—IRAK1—midbrain—schizophrenia	0.000204	0.0017	CbGeAlD
Crizotinib—ACVR1—nervous system—schizophrenia	0.000204	0.0017	CbGeAlD
Crizotinib—MAP3K12—nervous system—schizophrenia	0.000204	0.0017	CbGeAlD
Crizotinib—TESK1—cerebellum—schizophrenia	0.000203	0.0017	CbGeAlD
Crizotinib—MERTK—central nervous system—schizophrenia	0.000202	0.00169	CbGeAlD
Crizotinib—RPS6KB1—blood—schizophrenia	0.000202	0.00169	CbGeAlD
Crizotinib—LCK—blood—schizophrenia	0.000201	0.00168	CbGeAlD
Crizotinib—FGR—blood—schizophrenia	0.000201	0.00168	CbGeAlD
Crizotinib—CSF1R—telencephalon—schizophrenia	0.000201	0.00167	CbGeAlD
Crizotinib—RPS6KB1—midbrain—schizophrenia	0.0002	0.00167	CbGeAlD
Crizotinib—STK35—nervous system—schizophrenia	0.000199	0.00166	CbGeAlD
Crizotinib—LIMK2—central nervous system—schizophrenia	0.000198	0.00165	CbGeAlD
Crizotinib—PTK2B—endocrine gland—schizophrenia	0.000198	0.00165	CbGeAlD
Crizotinib—MERTK—cerebellum—schizophrenia	0.000198	0.00165	CbGeAlD
Crizotinib—AXL—midbrain—schizophrenia	0.000198	0.00165	CbGeAlD
Crizotinib—EPHA6—brain—schizophrenia	0.000197	0.00164	CbGeAlD
Crizotinib—JAK3—brain—schizophrenia	0.000197	0.00164	CbGeAlD
Crizotinib—RIPK2—endocrine gland—schizophrenia	0.000196	0.00164	CbGeAlD
Crizotinib—DCLK1—brain—schizophrenia	0.000196	0.00163	CbGeAlD
Crizotinib—ACVR1—central nervous system—schizophrenia	0.000196	0.00163	CbGeAlD
Crizotinib—MAP3K12—central nervous system—schizophrenia	0.000196	0.00163	CbGeAlD
Crizotinib—PLK4—brain—schizophrenia	0.000195	0.00162	CbGeAlD
Crizotinib—YES1—gonad—schizophrenia	0.000194	0.00162	CbGeAlD
Crizotinib—STK4—brain—schizophrenia	0.000194	0.00161	CbGeAlD
Crizotinib—LIMK2—cerebellum—schizophrenia	0.000194	0.00161	CbGeAlD
Crizotinib—NUAK2—cerebellum—schizophrenia	0.000193	0.00161	CbGeAlD
Crizotinib—SLK—blood—schizophrenia	0.000193	0.00161	CbGeAlD
Crizotinib—STK10—gonad—schizophrenia	0.000192	0.0016	CbGeAlD
Crizotinib—STK35—central nervous system—schizophrenia	0.000192	0.0016	CbGeAlD
Crizotinib—BMP2K—nervous system—schizophrenia	0.000192	0.0016	CbGeAlD
Crizotinib—MAP3K12—cerebellum—schizophrenia	0.000192	0.0016	CbGeAlD
Crizotinib—ACVR1—cerebellum—schizophrenia	0.000192	0.0016	CbGeAlD
Crizotinib—FLT3—cerebellum—schizophrenia	0.000192	0.0016	CbGeAlD
Crizotinib—EPHB4—blood—schizophrenia	0.000191	0.0016	CbGeAlD
Crizotinib—SLK—midbrain—schizophrenia	0.00019	0.00159	CbGeAlD
Crizotinib—JAK2—blood—schizophrenia	0.00019	0.00158	CbGeAlD
Crizotinib—EPHA4—endocrine gland—schizophrenia	0.00019	0.00158	CbGeAlD
Crizotinib—EPHB4—midbrain—schizophrenia	0.000189	0.00158	CbGeAlD
Crizotinib—EPHA2—blood—schizophrenia	0.000188	0.00157	CbGeAlD
Crizotinib—STK35—cerebellum—schizophrenia	0.000188	0.00156	CbGeAlD
Crizotinib—SRC—gonad—schizophrenia	0.000187	0.00156	CbGeAlD
Crizotinib—MAP3K2—endocrine gland—schizophrenia	0.000186	0.00155	CbGeAlD
Crizotinib—PTK2B—nervous system—schizophrenia	0.000185	0.00155	CbGeAlD
Crizotinib—BMP2K—central nervous system—schizophrenia	0.000185	0.00154	CbGeAlD
Crizotinib—CYP3A5—blood plasma—schizophrenia	0.000184	0.00154	CbGeAlD
Crizotinib—MAP4K5—blood—schizophrenia	0.000183	0.00153	CbGeAlD
Crizotinib—MAP3K3—blood—schizophrenia	0.000183	0.00153	CbGeAlD
Crizotinib—TEK—blood—schizophrenia	0.000183	0.00153	CbGeAlD
Crizotinib—EPHA5—brain—schizophrenia	0.000183	0.00153	CbGeAlD
Crizotinib—FER—brain—schizophrenia	0.000183	0.00153	CbGeAlD
Crizotinib—TYRO3—brain—schizophrenia	0.000183	0.00153	CbGeAlD
Crizotinib—ALK—brain—schizophrenia	0.000183	0.00153	CbGeAlD
Crizotinib—ABL2—cerebellum—schizophrenia	0.000183	0.00152	CbGeAlD
Crizotinib—PTK2—endocrine gland—schizophrenia	0.000182	0.00152	CbGeAlD
Crizotinib—TBK1—endocrine gland—schizophrenia	0.000182	0.00152	CbGeAlD
Crizotinib—LYN—brain—schizophrenia	0.000182	0.00152	CbGeAlD
Crizotinib—TYK2—endocrine gland—schizophrenia	0.000181	0.00151	CbGeAlD
Crizotinib—TNK1—brain—schizophrenia	0.000181	0.00151	CbGeAlD
Crizotinib—MAP4K5—midbrain—schizophrenia	0.000181	0.00151	CbGeAlD
Crizotinib—TEK—midbrain—schizophrenia	0.000181	0.00151	CbGeAlD
Crizotinib—MAP3K3—midbrain—schizophrenia	0.000181	0.00151	CbGeAlD
Crizotinib—BMP2K—cerebellum—schizophrenia	0.000181	0.00151	CbGeAlD
Crizotinib—BMPR1B—brain—schizophrenia	0.000179	0.00149	CbGeAlD
Crizotinib—MAP4K1—brain—schizophrenia	0.000179	0.00149	CbGeAlD
Crizotinib—MAP3K19—brain—schizophrenia	0.000179	0.00149	CbGeAlD
Crizotinib—PTK2B—central nervous system—schizophrenia	0.000178	0.00149	CbGeAlD
Crizotinib—EPHA4—nervous system—schizophrenia	0.000178	0.00148	CbGeAlD
Crizotinib—TNK2—brain—schizophrenia	0.000176	0.00147	CbGeAlD
Crizotinib—IGF1R—brain—schizophrenia	0.000176	0.00147	CbGeAlD
Crizotinib—RPS6KB1—endocrine gland—schizophrenia	0.000175	0.00146	CbGeAlD
Crizotinib—EPHB6—blood—schizophrenia	0.000175	0.00146	CbGeAlD
Crizotinib—PTK2B—cerebellum—schizophrenia	0.000174	0.00145	CbGeAlD
Crizotinib—FGR—endocrine gland—schizophrenia	0.000174	0.00145	CbGeAlD
Crizotinib—MAP3K2—nervous system—schizophrenia	0.000174	0.00145	CbGeAlD
Crizotinib—AXL—endocrine gland—schizophrenia	0.000174	0.00145	CbGeAlD
Crizotinib—MAP4K2—brain—schizophrenia	0.000173	0.00145	CbGeAlD
Crizotinib—RIPK2—cerebellum—schizophrenia	0.000173	0.00144	CbGeAlD
Crizotinib—EPHB6—midbrain—schizophrenia	0.000173	0.00144	CbGeAlD
Crizotinib—EPHA4—central nervous system—schizophrenia	0.000171	0.00143	CbGeAlD
Crizotinib—STK3—brain—schizophrenia	0.000171	0.00143	CbGeAlD
Crizotinib—TIE1—brain—schizophrenia	0.000171	0.00143	CbGeAlD
Crizotinib—PTK2—nervous system—schizophrenia	0.000171	0.00142	CbGeAlD
Crizotinib—TBK1—nervous system—schizophrenia	0.000171	0.00142	CbGeAlD
Crizotinib—TYK2—nervous system—schizophrenia	0.00017	0.00141	CbGeAlD
Crizotinib—YES1—blood—schizophrenia	0.000169	0.00141	CbGeAlD
Crizotinib—MAP3K2—central nervous system—schizophrenia	0.000168	0.0014	CbGeAlD
Crizotinib—CSF1R—gonad—schizophrenia	0.000168	0.0014	CbGeAlD
Crizotinib—STK10—blood—schizophrenia	0.000168	0.0014	CbGeAlD
Crizotinib—EPHA4—cerebellum—schizophrenia	0.000167	0.00139	CbGeAlD
Crizotinib—YES1—midbrain—schizophrenia	0.000167	0.00139	CbGeAlD
Crizotinib—TAOK3—blood—schizophrenia	0.000167	0.00139	CbGeAlD
Crizotinib—AURKA—brain—schizophrenia	0.000167	0.00139	CbGeAlD
Crizotinib—EPHB4—endocrine gland—schizophrenia	0.000166	0.00138	CbGeAlD
Crizotinib—TESK1—brain—schizophrenia	0.000165	0.00138	CbGeAlD
Crizotinib—TAOK3—midbrain—schizophrenia	0.000165	0.00137	CbGeAlD
Crizotinib—JAK2—endocrine gland—schizophrenia	0.000165	0.00137	CbGeAlD
Crizotinib—PTK2—central nervous system—schizophrenia	0.000164	0.00137	CbGeAlD
Crizotinib—TBK1—central nervous system—schizophrenia	0.000164	0.00137	CbGeAlD
Crizotinib—RPS6KB1—nervous system—schizophrenia	0.000164	0.00137	CbGeAlD
Crizotinib—MAP3K2—cerebellum—schizophrenia	0.000164	0.00137	CbGeAlD
Crizotinib—TYK2—central nervous system—schizophrenia	0.000163	0.00136	CbGeAlD
Crizotinib—FGR—nervous system—schizophrenia	0.000163	0.00136	CbGeAlD
Crizotinib—EPHA2—endocrine gland—schizophrenia	0.000163	0.00136	CbGeAlD
Crizotinib—SRC—blood—schizophrenia	0.000163	0.00136	CbGeAlD
Crizotinib—AXL—nervous system—schizophrenia	0.000163	0.00136	CbGeAlD
Crizotinib—MERTK—brain—schizophrenia	0.000161	0.00134	CbGeAlD
Crizotinib—TBK1—cerebellum—schizophrenia	0.000161	0.00134	CbGeAlD
Crizotinib—PTK2—cerebellum—schizophrenia	0.000161	0.00134	CbGeAlD
Crizotinib—TYK2—cerebellum—schizophrenia	0.00016	0.00133	CbGeAlD
Crizotinib—MAP3K3—endocrine gland—schizophrenia	0.000159	0.00132	CbGeAlD
Crizotinib—TEK—endocrine gland—schizophrenia	0.000159	0.00132	CbGeAlD
Crizotinib—MAP4K5—endocrine gland—schizophrenia	0.000159	0.00132	CbGeAlD
Crizotinib—ABL1—telencephalon—schizophrenia	0.000159	0.00132	CbGeAlD
Crizotinib—RPS6KB1—central nervous system—schizophrenia	0.000158	0.00132	CbGeAlD
Crizotinib—IRAK1—cerebellum—schizophrenia	0.000157	0.00131	CbGeAlD
Crizotinib—LIMK2—brain—schizophrenia	0.000157	0.00131	CbGeAlD
Crizotinib—FGR—central nervous system—schizophrenia	0.000157	0.00131	CbGeAlD
Crizotinib—NUAK2—brain—schizophrenia	0.000157	0.00131	CbGeAlD
Crizotinib—AXL—central nervous system—schizophrenia	0.000156	0.0013	CbGeAlD
Crizotinib—MAP3K12—brain—schizophrenia	0.000156	0.0013	CbGeAlD
Crizotinib—ACVR1—brain—schizophrenia	0.000156	0.0013	CbGeAlD
Crizotinib—RPS6KB1—cerebellum—schizophrenia	0.000155	0.00129	CbGeAlD
Crizotinib—JAK2—nervous system—schizophrenia	0.000154	0.00129	CbGeAlD
Crizotinib—AXL—cerebellum—schizophrenia	0.000153	0.00128	CbGeAlD
Crizotinib—STK35—brain—schizophrenia	0.000152	0.00127	CbGeAlD
Crizotinib—EPHA2—nervous system—schizophrenia	0.000152	0.00127	CbGeAlD
Crizotinib—MAP4K5—nervous system—schizophrenia	0.000149	0.00124	CbGeAlD
Crizotinib—MAP3K3—nervous system—schizophrenia	0.000149	0.00124	CbGeAlD
Crizotinib—TEK—nervous system—schizophrenia	0.000149	0.00124	CbGeAlD
Crizotinib—ABL2—brain—schizophrenia	0.000149	0.00124	CbGeAlD
Crizotinib—JAK2—central nervous system—schizophrenia	0.000148	0.00124	CbGeAlD
Crizotinib—SLK—cerebellum—schizophrenia	0.000147	0.00123	CbGeAlD
Crizotinib—EPHA2—central nervous system—schizophrenia	0.000147	0.00122	CbGeAlD
Crizotinib—BMP2K—brain—schizophrenia	0.000147	0.00122	CbGeAlD
Crizotinib—YES1—endocrine gland—schizophrenia	0.000147	0.00122	CbGeAlD
Crizotinib—EPHB4—cerebellum—schizophrenia	0.000146	0.00122	CbGeAlD
Crizotinib—CSF1R—blood—schizophrenia	0.000146	0.00122	CbGeAlD
Crizotinib—STK10—endocrine gland—schizophrenia	0.000145	0.00121	CbGeAlD
Crizotinib—JAK2—cerebellum—schizophrenia	0.000145	0.00121	CbGeAlD
Crizotinib—TAOK3—endocrine gland—schizophrenia	0.000145	0.00121	CbGeAlD
Crizotinib—CSF1R—midbrain—schizophrenia	0.000144	0.0012	CbGeAlD
Crizotinib—MAP3K3—central nervous system—schizophrenia	0.000143	0.00119	CbGeAlD
Crizotinib—TEK—central nervous system—schizophrenia	0.000143	0.00119	CbGeAlD
Crizotinib—MAP4K5—central nervous system—schizophrenia	0.000143	0.00119	CbGeAlD
Crizotinib—EPHB6—nervous system—schizophrenia	0.000142	0.00118	CbGeAlD
Crizotinib—PTK2B—brain—schizophrenia	0.000142	0.00118	CbGeAlD
Crizotinib—SRC—endocrine gland—schizophrenia	0.000141	0.00118	CbGeAlD
Crizotinib—RIPK2—brain—schizophrenia	0.000141	0.00117	CbGeAlD
Crizotinib—TEK—cerebellum—schizophrenia	0.00014	0.00117	CbGeAlD
Crizotinib—MAP3K3—cerebellum—schizophrenia	0.00014	0.00117	CbGeAlD
Crizotinib—MAP4K5—cerebellum—schizophrenia	0.00014	0.00117	CbGeAlD
Crizotinib—CYP3A4—blood plasma—schizophrenia	0.000138	0.00115	CbGeAlD
Crizotinib—YES1—nervous system—schizophrenia	0.000137	0.00114	CbGeAlD
Crizotinib—EPHB6—central nervous system—schizophrenia	0.000137	0.00114	CbGeAlD
Crizotinib—STK10—nervous system—schizophrenia	0.000136	0.00113	CbGeAlD
Crizotinib—EPHA4—brain—schizophrenia	0.000136	0.00113	CbGeAlD
Crizotinib—TAOK3—nervous system—schizophrenia	0.000136	0.00113	CbGeAlD
Crizotinib—EPHB6—cerebellum—schizophrenia	0.000134	0.00111	CbGeAlD
Crizotinib—MAP3K2—brain—schizophrenia	0.000133	0.00111	CbGeAlD
Crizotinib—ABL1—gonad—schizophrenia	0.000132	0.0011	CbGeAlD
Crizotinib—YES1—central nervous system—schizophrenia	0.000132	0.0011	CbGeAlD
Crizotinib—SRC—nervous system—schizophrenia	0.000132	0.0011	CbGeAlD
Crizotinib—STK10—central nervous system—schizophrenia	0.000131	0.00109	CbGeAlD
Crizotinib—TAOK3—central nervous system—schizophrenia	0.00013	0.00109	CbGeAlD
Crizotinib—PTK2—brain—schizophrenia	0.00013	0.00109	CbGeAlD
Crizotinib—TBK1—brain—schizophrenia	0.00013	0.00109	CbGeAlD
Crizotinib—TYK2—brain—schizophrenia	0.00013	0.00108	CbGeAlD
Crizotinib—YES1—cerebellum—schizophrenia	0.000129	0.00108	CbGeAlD
Crizotinib—STK10—cerebellum—schizophrenia	0.000128	0.00107	CbGeAlD
Crizotinib—IRAK1—brain—schizophrenia	0.000128	0.00107	CbGeAlD
Crizotinib—TAOK3—cerebellum—schizophrenia	0.000128	0.00106	CbGeAlD
Crizotinib—SRC—central nervous system—schizophrenia	0.000127	0.00106	CbGeAlD
Crizotinib—CSF1R—endocrine gland—schizophrenia	0.000127	0.00106	CbGeAlD
Crizotinib—RPS6KB1—brain—schizophrenia	0.000125	0.00105	CbGeAlD
Crizotinib—FGR—brain—schizophrenia	0.000125	0.00104	CbGeAlD
Crizotinib—SRC—cerebellum—schizophrenia	0.000124	0.00104	CbGeAlD
Crizotinib—AXL—brain—schizophrenia	0.000124	0.00104	CbGeAlD
Crizotinib—SLK—brain—schizophrenia	0.00012	0.000997	CbGeAlD
Crizotinib—EPHB4—brain—schizophrenia	0.000119	0.00099	CbGeAlD
Crizotinib—CSF1R—nervous system—schizophrenia	0.000119	0.000989	CbGeAlD
Crizotinib—JAK2—brain—schizophrenia	0.000118	0.000983	CbGeAlD
Crizotinib—EPHA2—brain—schizophrenia	0.000116	0.000971	CbGeAlD
Crizotinib—ABL1—blood—schizophrenia	0.000115	0.000963	CbGeAlD
Crizotinib—CSF1R—central nervous system—schizophrenia	0.000114	0.000952	CbGeAlD
Crizotinib—ABL1—midbrain—schizophrenia	0.000114	0.000951	CbGeAlD
Crizotinib—MAP3K3—brain—schizophrenia	0.000114	0.000947	CbGeAlD
Crizotinib—MAP4K5—brain—schizophrenia	0.000114	0.000947	CbGeAlD
Crizotinib—TEK—brain—schizophrenia	0.000114	0.000947	CbGeAlD
Crizotinib—CSF1R—cerebellum—schizophrenia	0.000112	0.00093	CbGeAlD
Crizotinib—EPHB6—brain—schizophrenia	0.000109	0.000905	CbGeAlD
Crizotinib—YES1—brain—schizophrenia	0.000105	0.000875	CbGeAlD
Crizotinib—STK10—brain—schizophrenia	0.000104	0.000867	CbGeAlD
Crizotinib—TAOK3—brain—schizophrenia	0.000104	0.000864	CbGeAlD
Crizotinib—SRC—brain—schizophrenia	0.000101	0.000842	CbGeAlD
Crizotinib—ABL1—endocrine gland—schizophrenia	0.0001	0.000835	CbGeAlD
Crizotinib—ABCB1—blood plasma—schizophrenia	9.8e-05	0.000817	CbGeAlD
Crizotinib—ABL1—nervous system—schizophrenia	9.37e-05	0.000782	CbGeAlD
Crizotinib—CSF1R—brain—schizophrenia	9.06e-05	0.000756	CbGeAlD
Crizotinib—ABL1—central nervous system—schizophrenia	9.02e-05	0.000752	CbGeAlD
Crizotinib—ABL1—cerebellum—schizophrenia	8.82e-05	0.000735	CbGeAlD
Crizotinib—ABL1—brain—schizophrenia	7.16e-05	0.000597	CbGeAlD
Crizotinib—CYP3A5—blood—schizophrenia	6.76e-05	0.000564	CbGeAlD
Crizotinib—CYP3A5—endocrine gland—schizophrenia	5.86e-05	0.000489	CbGeAlD
Crizotinib—ABCB1—forebrain—schizophrenia	5.37e-05	0.000448	CbGeAlD
Crizotinib—CYP3A4—blood—schizophrenia	5.07e-05	0.000423	CbGeAlD
Crizotinib—ABCB1—telencephalon—schizophrenia	4.94e-05	0.000412	CbGeAlD
Crizotinib—CYP3A4—endocrine gland—schizophrenia	4.4e-05	0.000367	CbGeAlD
Crizotinib—ABCB1—gonad—schizophrenia	4.12e-05	0.000344	CbGeAlD
Crizotinib—CYP3A4—nervous system—schizophrenia	4.12e-05	0.000343	CbGeAlD
Crizotinib—CYP3A4—central nervous system—schizophrenia	3.96e-05	0.000331	CbGeAlD
Crizotinib—ABCB1—blood—schizophrenia	3.59e-05	0.000299	CbGeAlD
Crizotinib—ABCB1—midbrain—schizophrenia	3.55e-05	0.000296	CbGeAlD
Crizotinib—ABCB1—endocrine gland—schizophrenia	3.11e-05	0.00026	CbGeAlD
Crizotinib—ABCB1—nervous system—schizophrenia	2.91e-05	0.000243	CbGeAlD
Crizotinib—ABCB1—central nervous system—schizophrenia	2.81e-05	0.000234	CbGeAlD
Crizotinib—ABCB1—cerebellum—schizophrenia	2.74e-05	0.000229	CbGeAlD
Crizotinib—ABCB1—brain—schizophrenia	2.23e-05	0.000186	CbGeAlD
Crizotinib—PTK2—Immune System—EP300—schizophrenia	1.67e-06	1e-05	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—TP53—schizophrenia	1.67e-06	1e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—DRD4—schizophrenia	1.67e-06	1e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CYP2D6—schizophrenia	1.66e-06	9.99e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—SNAP25—schizophrenia	1.66e-06	9.99e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NRG1—schizophrenia	1.66e-06	9.99e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PRL—schizophrenia	1.66e-06	9.96e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—YWHAZ—schizophrenia	1.65e-06	9.92e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MEF2C—schizophrenia	1.65e-06	9.9e-06	CbGpPWpGaD
Crizotinib—YES1—Immune System—EP300—schizophrenia	1.65e-06	9.9e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—ESR1—schizophrenia	1.64e-06	9.88e-06	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—AKT1—schizophrenia	1.64e-06	9.87e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—GSK3B—schizophrenia	1.64e-06	9.87e-06	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—AKT1—schizophrenia	1.63e-06	9.82e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—APOE—schizophrenia	1.63e-06	9.81e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GAPDH—schizophrenia	1.62e-06	9.77e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—AKT1—schizophrenia	1.62e-06	9.75e-06	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—AKT1—schizophrenia	1.62e-06	9.75e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—GSK3B—schizophrenia	1.62e-06	9.73e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—ERBB3—schizophrenia	1.61e-06	9.7e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—GSK3B—schizophrenia	1.61e-06	9.7e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—APOA1—schizophrenia	1.61e-06	9.69e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CLOCK—schizophrenia	1.61e-06	9.68e-06	CbGpPWpGaD
Crizotinib—TBK1—Immune System—AKT1—schizophrenia	1.59e-06	9.59e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—YWHAZ—schizophrenia	1.59e-06	9.57e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CNR1—schizophrenia	1.59e-06	9.57e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PLA2G4A—schizophrenia	1.58e-06	9.53e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PIP4K2A—schizophrenia	1.58e-06	9.51e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—AKT1—schizophrenia	1.58e-06	9.5e-06	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—AKT1—schizophrenia	1.57e-06	9.46e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—TPH2—schizophrenia	1.57e-06	9.43e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CACNB2—schizophrenia	1.57e-06	9.43e-06	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	1.57e-06	9.43e-06	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—TP53—schizophrenia	1.57e-06	9.43e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—EP300—schizophrenia	1.56e-06	9.39e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—ERBB3—schizophrenia	1.56e-06	9.36e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NRG1—schizophrenia	1.55e-06	9.35e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—DRD2—schizophrenia	1.55e-06	9.34e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR7—schizophrenia	1.55e-06	9.34e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—MTHFR—schizophrenia	1.55e-06	9.32e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—EP300—schizophrenia	1.54e-06	9.28e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—S100B—schizophrenia	1.54e-06	9.28e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—DPYD—schizophrenia	1.54e-06	9.28e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MEF2C—schizophrenia	1.54e-06	9.27e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—GSK3B—schizophrenia	1.53e-06	9.23e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—EP300—schizophrenia	1.53e-06	9.2e-06	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—AKT1—schizophrenia	1.53e-06	9.2e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—GSK3B—schizophrenia	1.53e-06	9.2e-06	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—TP53—schizophrenia	1.53e-06	9.19e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—FOS—schizophrenia	1.52e-06	9.14e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—EP300—schizophrenia	1.52e-06	9.12e-06	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—APOA1—schizophrenia	1.51e-06	9.08e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CYP1A2—schizophrenia	1.5e-06	9.04e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR2A—schizophrenia	1.5e-06	9.01e-06	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—TP53—schizophrenia	1.49e-06	8.99e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—YWHAZ—schizophrenia	1.49e-06	8.96e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—GSK3B—schizophrenia	1.49e-06	8.96e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—TH—schizophrenia	1.48e-06	8.91e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ERBB4—schizophrenia	1.48e-06	8.88e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PRL—schizophrenia	1.47e-06	8.82e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—ERBB3—schizophrenia	1.46e-06	8.76e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—APOE—schizophrenia	1.44e-06	8.68e-06	CbGpPWpGaD
Crizotinib—JAK3—Immune System—AKT1—schizophrenia	1.44e-06	8.68e-06	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—AKT1—schizophrenia	1.44e-06	8.67e-06	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—AKT1—schizophrenia	1.44e-06	8.63e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CACNA1C—schizophrenia	1.43e-06	8.63e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP26B1—schizophrenia	1.43e-06	8.6e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—APOA1—schizophrenia	1.43e-06	8.58e-06	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—AKT1—schizophrenia	1.43e-06	8.58e-06	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—AKT1—schizophrenia	1.41e-06	8.51e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—GSK3B—schizophrenia	1.41e-06	8.49e-06	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—AKT1—schizophrenia	1.41e-06	8.47e-06	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TNF—schizophrenia	1.41e-06	8.46e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR2A—schizophrenia	1.4e-06	8.43e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—EP300—schizophrenia	1.4e-06	8.42e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PIK3C2A—schizophrenia	1.4e-06	8.41e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—APOE—schizophrenia	1.39e-06	8.38e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PLA2G4A—schizophrenia	1.39e-06	8.35e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—APOA1—schizophrenia	1.38e-06	8.28e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—EP300—schizophrenia	1.38e-06	8.27e-06	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—TP53—schizophrenia	1.37e-06	8.26e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL1B—schizophrenia	1.37e-06	8.26e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL1B—schizophrenia	1.37e-06	8.22e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—S100B—schizophrenia	1.37e-06	8.22e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NRG1—schizophrenia	1.36e-06	8.19e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—EP300—schizophrenia	1.36e-06	8.15e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—GSK3B—schizophrenia	1.35e-06	8.14e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MEF2C—schizophrenia	1.35e-06	8.12e-06	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—AKT1—schizophrenia	1.35e-06	8.12e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—FOS—schizophrenia	1.34e-06	8.09e-06	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—AKT1—schizophrenia	1.34e-06	8.06e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—ESR1—schizophrenia	1.33e-06	8e-06	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	1.32e-06	7.96e-06	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—AKT1—schizophrenia	1.32e-06	7.96e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ERBB4—schizophrenia	1.31e-06	7.86e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—YWHAZ—schizophrenia	1.3e-06	7.85e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—APOE—schizophrenia	1.3e-06	7.84e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—EP300—schizophrenia	1.3e-06	7.8e-06	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—AKT1—schizophrenia	1.29e-06	7.76e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—APOA1—schizophrenia	1.29e-06	7.75e-06	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—AKT1—schizophrenia	1.29e-06	7.73e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL1B—schizophrenia	1.29e-06	7.73e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ERBB3—schizophrenia	1.28e-06	7.67e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GCLM—schizophrenia	1.27e-06	7.67e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—TPH1—schizophrenia	1.27e-06	7.67e-06	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—AKT1—schizophrenia	1.27e-06	7.66e-06	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—AKT1—schizophrenia	1.27e-06	7.63e-06	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—AKT1—schizophrenia	1.27e-06	7.62e-06	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—AKT1—schizophrenia	1.26e-06	7.59e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—COMT—schizophrenia	1.26e-06	7.57e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—EP300—schizophrenia	1.26e-06	7.57e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—SNAP25—schizophrenia	1.25e-06	7.54e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP2D6—schizophrenia	1.25e-06	7.54e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GSTP1—schizophrenia	1.25e-06	7.54e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—MAOA—schizophrenia	1.25e-06	7.52e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—GSK3B—schizophrenia	1.25e-06	7.52e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—ESR1—schizophrenia	1.24e-06	7.48e-06	CbGpPWpGaD
Crizotinib—CDK7—Disease—AKT1—schizophrenia	1.24e-06	7.48e-06	CbGpPWpGaD
Crizotinib—BLK—Immune System—AKT1—schizophrenia	1.24e-06	7.44e-06	CbGpPWpGaD
Crizotinib—FGR—Immune System—AKT1—schizophrenia	1.23e-06	7.41e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PLA2G4A—schizophrenia	1.23e-06	7.39e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR2A—schizophrenia	1.23e-06	7.39e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—EP300—schizophrenia	1.23e-06	7.38e-06	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—AKT1—schizophrenia	1.22e-06	7.36e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—EP300—schizophrenia	1.22e-06	7.35e-06	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—TP53—schizophrenia	1.22e-06	7.31e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—GSK3B—schizophrenia	1.21e-06	7.26e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NRG1—schizophrenia	1.21e-06	7.25e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PRKD1—schizophrenia	1.2e-06	7.21e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MEF2C—schizophrenia	1.19e-06	7.19e-06	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—AKT1—schizophrenia	1.19e-06	7.17e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ABCB1—schizophrenia	1.19e-06	7.14e-06	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—AKT1—schizophrenia	1.16e-06	6.98e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—YWHAZ—schizophrenia	1.15e-06	6.95e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GSTM1—schizophrenia	1.15e-06	6.93e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PLA2G4A—schizophrenia	1.15e-06	6.93e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—EP300—schizophrenia	1.15e-06	6.91e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—APOE—schizophrenia	1.14e-06	6.87e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP1A2—schizophrenia	1.13e-06	6.82e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ERBB3—schizophrenia	1.13e-06	6.79e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—GSK3B—schizophrenia	1.13e-06	6.79e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—APOA1—schizophrenia	1.13e-06	6.79e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL1B—schizophrenia	1.13e-06	6.77e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—TH—schizophrenia	1.12e-06	6.72e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TP53—schizophrenia	1.1e-06	6.64e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ESR1—schizophrenia	1.09e-06	6.56e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR2A—schizophrenia	1.09e-06	6.54e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—EP300—schizophrenia	1.08e-06	6.49e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—EP300—schizophrenia	1.06e-06	6.4e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—EP300—schizophrenia	1.06e-06	6.38e-06	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—AKT1—schizophrenia	1.05e-06	6.29e-06	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—AKT1—schizophrenia	1.04e-06	6.28e-06	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—AKT1—schizophrenia	1.03e-06	6.17e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—MTHFR—schizophrenia	1.02e-06	6.12e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—APOE—schizophrenia	1.01e-06	6.08e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—EP300—schizophrenia	1.01e-06	6.07e-06	CbGpPWpGaD
Crizotinib—PTK2—Immune System—AKT1—schizophrenia	1.01e-06	6.07e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—EP300—schizophrenia	1.01e-06	6.05e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—AKT1—schizophrenia	1e-06	6.03e-06	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—AKT1—schizophrenia	1e-06	6.03e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GAPDH—schizophrenia	1e-06	6.02e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—APOA1—schizophrenia	9.99e-07	6.01e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL1B—schizophrenia	9.96e-07	5.99e-06	CbGpPWpGaD
Crizotinib—YES1—Immune System—AKT1—schizophrenia	9.95e-07	5.98e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CLOCK—schizophrenia	9.91e-07	5.96e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—GSK3B—schizophrenia	9.89e-07	5.95e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TP53—schizophrenia	9.84e-07	5.92e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—EP300—schizophrenia	9.8e-07	5.9e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TP53—schizophrenia	9.7e-07	5.84e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CACNB2—schizophrenia	9.66e-07	5.81e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—TPH2—schizophrenia	9.66e-07	5.81e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ESR1—schizophrenia	9.65e-07	5.8e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—DPYD—schizophrenia	9.51e-07	5.72e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—COMT—schizophrenia	9.5e-07	5.72e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—APOE—schizophrenia	9.48e-07	5.7e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GSTP1—schizophrenia	9.46e-07	5.69e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—AKT1—schizophrenia	9.44e-07	5.68e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MAOA—schizophrenia	9.43e-07	5.68e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—APOA1—schizophrenia	9.37e-07	5.63e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—AKT1—schizophrenia	9.32e-07	5.61e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—EP300—schizophrenia	9.29e-07	5.59e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TP53—schizophrenia	9.28e-07	5.58e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—AKT1—schizophrenia	9.24e-07	5.56e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—AKT1—schizophrenia	9.16e-07	5.51e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TP53—schizophrenia	9e-07	5.42e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—EP300—schizophrenia	8.91e-07	5.36e-06	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—AKT1—schizophrenia	8.87e-07	5.34e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CACNA1C—schizophrenia	8.84e-07	5.32e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—GSK3B—schizophrenia	8.75e-07	5.26e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PLA2G4A—schizophrenia	8.69e-07	5.23e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GSTM1—schizophrenia	8.69e-07	5.23e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PIK3C2A—schizophrenia	8.61e-07	5.18e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—AKT1—schizophrenia	8.46e-07	5.09e-06	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—AKT1—schizophrenia	8.37e-07	5.03e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—AKT1—schizophrenia	8.31e-07	5e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—EP300—schizophrenia	8.22e-07	4.95e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—AKT1—schizophrenia	8.19e-07	4.93e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—EP300—schizophrenia	7.94e-07	4.77e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—AKT1—schizophrenia	7.84e-07	4.72e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SNAP25—schizophrenia	7.72e-07	4.65e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP2D6—schizophrenia	7.72e-07	4.65e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TP53—schizophrenia	7.72e-07	4.65e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MTHFR—schizophrenia	7.68e-07	4.62e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TP53—schizophrenia	7.62e-07	4.58e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—AKT1—schizophrenia	7.6e-07	4.57e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—AKT1—schizophrenia	7.6e-07	4.57e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—EP300—schizophrenia	7.43e-07	4.47e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—AKT1—schizophrenia	7.42e-07	4.46e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—AKT1—schizophrenia	7.38e-07	4.44e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TP53—schizophrenia	7.22e-07	4.35e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—APOE—schizophrenia	7.15e-07	4.3e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—APOA1—schizophrenia	7.07e-07	4.25e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TP53—schizophrenia	7.01e-07	4.22e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP1A2—schizophrenia	6.99e-07	4.2e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—AKT1—schizophrenia	6.94e-07	4.18e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—TH—schizophrenia	6.88e-07	4.14e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—AKT1—schizophrenia	6.52e-07	3.92e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—EP300—schizophrenia	6.51e-07	3.91e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—AKT1—schizophrenia	6.43e-07	3.87e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—AKT1—schizophrenia	6.41e-07	3.86e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—AKT1—schizophrenia	6.1e-07	3.67e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—AKT1—schizophrenia	6.08e-07	3.66e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—AKT1—schizophrenia	5.92e-07	3.56e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—COMT—schizophrenia	5.85e-07	3.52e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GSTP1—schizophrenia	5.83e-07	3.5e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MAOA—schizophrenia	5.81e-07	3.5e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—EP300—schizophrenia	5.76e-07	3.46e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TP53—schizophrenia	5.68e-07	3.42e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—AKT1—schizophrenia	5.61e-07	3.38e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ABCB1—schizophrenia	5.52e-07	3.32e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—EP300—schizophrenia	5.4e-07	3.25e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—AKT1—schizophrenia	5.38e-07	3.24e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PLA2G4A—schizophrenia	5.35e-07	3.22e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GSTM1—schizophrenia	5.35e-07	3.22e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TP53—schizophrenia	5.31e-07	3.2e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—AKT1—schizophrenia	4.97e-07	2.99e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—AKT1—schizophrenia	4.8e-07	2.88e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MTHFR—schizophrenia	4.73e-07	2.85e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TP53—schizophrenia	4.66e-07	2.8e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—AKT1—schizophrenia	4.49e-07	2.7e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—APOE—schizophrenia	4.41e-07	2.65e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—APOA1—schizophrenia	4.35e-07	2.62e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TP53—schizophrenia	4.12e-07	2.48e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—EP300—schizophrenia	4.07e-07	2.45e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—AKT1—schizophrenia	3.93e-07	2.36e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—AKT1—schizophrenia	3.48e-07	2.09e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—AKT1—schizophrenia	3.26e-07	1.96e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—EP300—schizophrenia	2.51e-07	1.51e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—AKT1—schizophrenia	2.46e-07	1.48e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—AKT1—schizophrenia	1.52e-07	9.13e-07	CbGpPWpGaD
